A+ R A-

IWWM-10 Session 9: Clinical Trials Updates in WM: Ibrutinib

The following abstracts represent the presentations given at IWWM-10 (NYC-2018), Session 9: Clinical Trials Updates in WM: Ibrutinib

Session Chair: Lia Palomba (USA)

Ibrutinib monotherapy in treatment-naïve WM patients S. Treon (USA)

Long term follow-up of ibrutinib monotherapy in previously-treated WM patients: Update of pivotal trial R. Advani (USA)

Ibrutinib monotherapy in rituximab-refractory WM patients J. Trotman (Australia)

Randomized study of ibrutinib/rituximab versus rituximab in symptomatic WM patients M. Dimopoulos (Greece)

New York 2018 (IWWM-10)

New York 2018 Conference Chairs

  • Jorge Castillo, MD (Dana-Farber)
  • Richard Furman, MD (Cornell University)
  • M. Lia Palomba, MD (Memorial Sloan Kettering)
  • Steven Treon, MD, PhD (Dana-Farber)
  • Chris Patterson - Secretariat (Dana-Farber)

The New York 2018 Scientific Committee members:

Ranjana Advani, MD (USA)
Jorge Castillo MD (USA)
Meletios Dimopoulos MD (Greece)
Ramón García-Sanz MD, PhD (Spain)
Zachary Hunter, PhD (USA)
Efstathios Kastritis, MD, PhD (Greece)
Marie Jóse Kersten MD, PhD (Netherlands)
Douglas E Joshua AM (Australia)
Véronique Leblond MD (France)
Giampaolo Merlini MD (Italy)
Roger Owen MD, MRCP, FRCPath (UK)
S.T. Pals, MD, PhD (Netherlands)
Marvin Stone, MD (USA)
Marzia Varretoni, MD (Italy)

Registration for this meeting is now closed.

New York 2018 (IWWM-10) was held at the New York Marriott Downtown in New York City.

New York Marriott Downtown

Click here to download our New York City visitor's guide